Actelion Spinoff Loses Bid To Lengthen Patent Term
A drug company Actelion Pharmaceuticals Ltd. spun off when it was purchased by Johnson & Johnson in 2017 can't get 99 days added to the term of a patent to make...To view the full article, register now.
Already a subscriber? Click here to view full article